Score Overview
See the full market ranking โ
Tonix Pharmaceuticals Holding Corp fundamental performance
Across Tonix Pharmaceuticals Holding Corp's full reported history, from 2012 to 2025, revenue grew from $ 1.88K to $ 13M and net income went from -$ 9.45K to -$ 124M. Revenue increased in 36% of the years measured; net income in 21%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 11.97 | โ |
1 Year2025-08-12 | $ 59.76 | -79.97% |
5 Years2021-08-12 | $ 448K | -100.00% |
10 Years2016-08-12 | $ 1000K | -100.00% |
All Time2012-05-10 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2012-05-10 |
|---|---|---|---|---|---|
| Price | $ 11.97 | $ 59.76 | $ 448K | $ 1000K | $ 1000K |
| Return | โ | -79.97% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 17M | -$ 147M | $ 185M |
| 2025 | $ 13M | -$ 124M | $ 207M |
| 2024 | $ 10M | -$ 130M | $ 98M |
| 2023 | $ 7M | -$ 116M | $ 24M |
| 2022 | $ 9M | -$ 115M | $ 120M |
| 2021 | $ 0.00 | -$ 92M | $ 178M |
| 2020 | $ 2M | -$ 50M | $ 77M |
| 2019 | $ 0.00 | -$ 28M | $ 11M |
| 2018 | $ 0.00 | -$ 26M | $ 25M |
| 2017 | $ 0.00 | -$ 21M | $ 25M |
| 2016 | $ 0.00 | -$ 38M | $ 26M |
| 2015 | $ 0.00 | -$ 48M | $ 43M |
| 2014 | $ 0.00 | -$ 27M | $ 38M |
| 2013 | $ 0.00 | -$ 10M | $ 8M |
| IPO2012 | $ 1.88K | -$ 9.45K | $ 1M |
Explore beyond TNXP
You're looking at Tonix Pharmaceuticals Holding Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
